
Crowell & Moring has expanded its antitrust bench with the addition of Stefan Meisner, a first-chair defense litigator with extensive transactional and criminal antitrust investigations experience. Meisner joins as a partner in the Antitrust and Competition Group and brings more than two decades of experience representing Fortune 500 companies in significant, cross-jurisdictional antitrust matters.
Meisner defends corporations in high-stakes antitrust matters and criminal antitrust investigations. His practice focuses on complex, multi-district class action litigation alleging Sherman Act violations, US Department of Justice investigations, merger investigations, and intellectual property issues. In addition, Meisner crafts global strategies for addressing cartel prosecutions and defenses, from the inception of government investigations to the initiation of civil class action and opt-out litigation in a variety of jurisdictions.
“In addition to being a top-notch civil antitrust litigator, Stefan is an exceptionally well-rounded antitrust lawyer who can lead M&A transactions and guide clients in complex criminal antitrust matters,” said Philip T. Inglima, chair of Crowell & Moring. “Stefan is a great strategic fit as the firm and our clients continue to grow internationally. A significant focus of his practice is advising clients on aspects of their global expansion, including strategies for addressing cartel prosecutions and defenses and tailored compliance counseling.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas